These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15963969

  • 1. Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors.
    Hess G, Runkel S, Zdunek D, Hitzler WE.
    Clin Chim Acta; 2005 Oct; 360(1-2):187-93. PubMed ID: 15963969
    [Abstract] [Full Text] [Related]

  • 2. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G, Runkel S, Zdunek D, Hitzler WE.
    Clin Lab; 2005 Oct; 51(3-4):167-72. PubMed ID: 15819172
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes.
    Tildesley HD, Aydin CM, Ignaszewski A, Strelzow JA, Yu E, Bondy G.
    Int J Cardiol; 2007 Feb 14; 115(3):312-7. PubMed ID: 16824633
    [Abstract] [Full Text] [Related]

  • 5. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM, Rauh M, Zink S, Singer H.
    Acta Paediatr; 2006 Jul 14; 95(7):805-9. PubMed ID: 16801175
    [Abstract] [Full Text] [Related]

  • 6. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.
    Prontera C, Zucchelli GC, Vittorini S, Storti S, Emdin M, Clerico A.
    Clin Chim Acta; 2009 Feb 14; 400(1-2):70-3. PubMed ID: 18992732
    [Abstract] [Full Text] [Related]

  • 7. N-terminal ProBNP distribution and correlations with biological characteristics in apparently healthy Greek population: ATTICA study.
    Fragopoulou E, Panagiotakos DB, Pitsavos C, Chrysohoou C, Nomikos T, Evangelopoulos A, Katsagoni C, Skoumas J, Antonopoulou S, Stefanadis C.
    Angiology; 2010 May 14; 61(4):397-404. PubMed ID: 19815605
    [Abstract] [Full Text] [Related]

  • 8. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 9. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL.
    Am Heart J; 2005 Apr 13; 149(4):744-50. PubMed ID: 15990762
    [Abstract] [Full Text] [Related]

  • 10. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J, Svensson SE.
    Clin Endocrinol (Oxf); 2006 Dec 13; 65(6):760-6. PubMed ID: 17121527
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
    Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V, FINNSEPSIS Study Group.
    Crit Care Med; 2007 May 13; 35(5):1277-83. PubMed ID: 17414731
    [Abstract] [Full Text] [Related]

  • 13. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
    Alehagen U, Goetze JP, Dahlström U.
    Clin Chim Acta; 2007 Jul 13; 382(1-2):8-14. PubMed ID: 17433809
    [Abstract] [Full Text] [Related]

  • 14. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM, Fahoum SK, Shamia MG.
    Clin Lab; 2007 Jul 13; 53(1-2):35-9. PubMed ID: 17323823
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, Wong A, Murakami MM, Kaczmarek J, Apple FS, Miller WL, Hartman K, Jaffe AS.
    Clin Chim Acta; 2007 Jul 13; 386(1-2):20-4. PubMed ID: 17854790
    [Abstract] [Full Text] [Related]

  • 17. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL, Qiu YR, Zhou F, Feng PF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 13; 28(5):866-9. PubMed ID: 18504223
    [Abstract] [Full Text] [Related]

  • 18. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov 13; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 19. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.